An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children

NCT00002015 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Ganciclovir

Sponsor

Roche Global Development